ArticleJournal of hematology & oncology2018

Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients.

Jiayi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.